Systematic Financial Management LP Has $15.90 Million Holdings in InMode Ltd. $INMD

Systematic Financial Management LP cut its holdings in InMode Ltd. (NASDAQ:INMD) by 4.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,082,416 shares of the healthcare company’s stock after selling 55,006 shares during the quarter. Systematic Financial Management LP owned approximately 1.71% of InMode worth $15,901,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of INMD. Leonteq Securities AG acquired a new stake in InMode in the fourth quarter valued at about $26,000. Advisory Services Network LLC acquired a new stake in InMode in the third quarter valued at about $37,000. State of Alaska Department of Revenue acquired a new stake in InMode in the third quarter valued at about $52,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of InMode during the third quarter valued at about $69,000. Finally, Rothschild Investment LLC acquired a new stake in shares of InMode during the third quarter valued at about $85,000. 68.04% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

INMD has been the topic of a number of recent research reports. BTIG Research reissued a “neutral” rating on shares of InMode in a research note on Monday, January 26th. Barclays set a $19.00 price target on InMode and gave the company an “overweight” rating in a research note on Thursday, May 7th. Finally, Robert W. Baird cut their price target on InMode from $17.00 to $14.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $16.00.

InMode Price Performance

Shares of INMD opened at $13.74 on Monday. InMode Ltd. has a 1 year low of $12.72 and a 1 year high of $16.74. The company has a market capitalization of $870.55 million, a price-to-earnings ratio of 10.10 and a beta of 1.97. The business has a 50-day moving average of $13.90 and a 200-day moving average of $14.23.

InMode (NASDAQ:INMD) last issued its quarterly earnings data on Wednesday, May 6th. The healthcare company reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). InMode had a return on equity of 13.47% and a net margin of 23.27%.The company had revenue of $82.02 million for the quarter, compared to the consensus estimate of $79.84 million. During the same quarter last year, the business earned $0.31 earnings per share. InMode’s revenue was up 5.3% compared to the same quarter last year.

About InMode

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.